CNMD (Conmed) Stock Based Compensation: $20 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CNMD Conmed Corp CNMD
80 GF Score
Price $51.38
GF Value $67.46
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Conmed Stock Based Compensation?

Conmed CNMD +0.25% 80 Stock Based Compensation is $20 Mil as of Jun. 2026. GuruFocus rates CNMD with a GF Score™ of 80/100 and a GF Value™ of $67.46 (Modestly Undervalued). The stock has 5 warning signs investors should review.

Conmed's Stock Based Compensation for the three months ended in Jun. 2026 was $5 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Jun. 2026 was $20 Mil.

Conmed Stock Based Compensation Related Terms

Conmed Stock Based Compensation Historical Data

* Premium members only.

The historical data trend for Conmed's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Conmed Stock Based Compensation Chart

Conmed Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Stock Based Compensation
Get a 7-Day Free Trial Premium Member Only Premium Member Only 16.34 21.73 24.26 25.56 28.32

Conmed Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.90 4.59 4.97 5.50 5.23
CNMD
80GF Score
Conmed Corp CNMD
Stock Based Compensation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Conmed Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $20 Mil.

What does a Stock Based Compensation of $20 Mil mean?
Conmed (CNMD) has a Stock Based Compensation of $20 Mil as of Jun. 2026. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Conmed and its competitors.
Is Conmed's Stock Based Compensation too high?
Conmed's current Stock Based Compensation is $20 Mil. Overall, Conmed has a GF Score™ of 80/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Conmed's Stock Based Compensation compare to ATEC and AORT?
Conmed's Stock Based Compensation of $20 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Stock Based Compensation for a Medical Devices & Instruments company?
A good Stock Based Compensation depends on the Medical Devices & Instruments industry context. However, Stock Based Compensation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Stock Based Compensation mean?
A high Stock Based Compensation can signal that a stock is expensive relative to its fundamentals. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Conmed and its competitors. Conmed's current Stock Based Compensation is $20 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Conmed stock overvalued right now?
Based on GuruFocus' analysis, Conmed (CNMD) is currently considered Modestly Undervalued. The stock's GF Value™ is $67.46, compared to a current price of $51.38 — trading 23.8% below its estimated fair value. The current Stock Based Compensation is $20 Mil. Conmed's overall GF Score™ is 80/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Stock Based Compensation calculated?
Stock Based Compensation is calculated from a company's financial statements. For Conmed (CNMD), the current Stock Based Compensation is $20 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Conmed (CNMD) Overvalued in 2026?

Based on GuruFocus' analysis, Conmed stock appears to be undervalued. The current stock price of $51.38 is trading 23.8% below its estimated GF Value™ of $67.46. GuruFocus considers Conmed to be Modestly Undervalued.

Key valuation signals for CNMD:

  • Stock Based Compensation: $20 Mil
  • GF Value™: $67.46 vs. price of $51.38 (23.8% below fair value)
  • GF Score™: 80/100 with 5 warning signs

No single metric tells the full story. See the CNMD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Conmed Business Description

Other Exchanges EC8:Germany
Address 11311 Concept Boulevard, Largo, FL, USA, 33773
Conmed Corp is a medical technology company that provides devices and equipment for surgical procedures. The company's products are used by surgeons and other healthcare professionals across specialties, including orthopedics, general surgery, gynecology, thoracic surgery, and gastroenterology. Geographically, the company operates in the United States, Europe, the Middle East & Africa, Asia Pacific, and the Americas, excluding the United States. The majority of revenue is generated from the United States.
80GF Score

Get the complete analysis for CNMD

Stock Based Compensation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$51.38
Price
$67.46
GF Value